ARCHIVES

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

This article is from The Cancer Letter archive.

Vol. 04 No. 44 | November 3, 1978

Download PDF Visit The Full Archive

Related Articles

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

October 25, 1985

“Optimal Criteria,” For Hospitals Treating Cancer Patients Developed; NCI Won’t Try Forcing Changes

November 1, 1974

NCI, NINCDS Need Patients For Brain, Breast Studies

September 10, 1982

Black Women More Likely To Delay Diagnosis, Treatment

July 29, 2005

Fisher Address Gap Between Clinicians Investigators, A Threat To Patient Welfare

May 28, 1993